Risdiplam 750micrograms/ml oral solution sugar free
NHS hospitals in England used £125,061,641 of indicative cost of Risdiplam 750micrograms/ml oral solution sugar free in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 2.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Risdiplam 750micrograms/ml oral solution sugar free: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Risdiplam 750micrograms/ml oral solution sugar free most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £12,805,900 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £9,416,800 |
| Oxford University Hospitals Nhs Ft | £9,140,300 |
| University Hospital Southampton Nhs Ft | £7,181,100 |
| Salford Royal Nhs Foundation Trust | £6,912,500 |
| Cambridge Univ Hosp Nhs Foundation Trust | £6,509,600 |
| Sheffield Teaching Hospitals Nhs Trust | £5,616,900 |
| Guy's & St Thomas' Nhs Foundation Trust | £5,561,600 |
| King's College Hpl Nhs Foundation Trust | £5,340,400 |
| Robert Jones & Agnes Hunt Hpl Nhs Trust | £5,300,900 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.